Meeting Abstract RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- PERCUTANEOUS ENDOSCOPIC REMOVAL OF A LARGE APPENDICOLITH
- Percutaneous Sharp Recanalization of a Surgically Ligated Infrarenal Inferior Vena Cava
- Performance of the 17-gene genomic prostate score test in men with prostate cancer (PCa) managed with active surveillance (AS): Results from the Canary Prostate Active Surveillance Study (PASS).
- Performing Transcarotid Artery Revascularization Outside of Manufacturer's Instructions for Use Is Safe but Has Higher Reintervention Rates
- Peripheral Retinal Vascular Leakage as an Inflammatory Marker in Psoriasis
- Peripheral retinal vascular leakage in moderate to severe psoriasis: A pilot study
- Perivascular macrophages in the neonatal macaque brain undergo massive necroptosis after simian immunodeficiency virus infection
- Persistent reduction of response to secukinumab is uncommon in plaque psoriasis patients: A pooled analysis of FIXTURE and CLEAR
- Persistent reduction of response to secukinumab is uncommon in plaque psoriasis patients: a pooled analysis of FIXTURE and CLEAR
- PGE2 Receptors in Subpopulations of Primate Granulosa Cells: Differential Expression During the Periovulatory Interval.
- PGE2 REGULATES THE PLASMINOGEN ACTIVATOR PATHWAY IN HUMAN ENDOMETRIAL ENDOTH LIAL CELLS THROUGH PROSTAGLANIN-E2 RECEPTORS (PTGER) 1 AND 2
- PGE2 REGULATES THE PLASMINOGEN ACTIVATOR PATHWAY IN HUMAN ENDOMETRIAL ENDOTHELIAL CELLS: DIFFERENCES BETWEEN NORMAL AND HEAVY MENSTRUAL BLEEDERS.
- Pharmacokinetic analyses show limited systemic exposure with topical glycopyrronium tosylate
- Pharmacokinetics and pharmacodynamics of twice-yearly depemokimab in the randomized, double-blind, placebo-controlled parallel phase III ANCHOR-1/2 Trials
- Pharmacokinetics and Pharmacodynamics of Twice-Yearly Depemokimab in the Randomized, Double-Blind, Placebo-Controlled Parallel Phase III ANCHOR-1/2 Trials
- Pharmacokinetics, Efficacy and Safety after Multiple Switches from Reference Adalimumab to Adalimumab Biosimilar (CT-P17) in comparison with the Maintenance Group (Reference Adalimumab) in Patients with Moderate-to-Severe Plaque Psoriasis: Week 52 Results
- Pharmacokinetics/Pharmacodynamics of Tenofovir and Tenofovir Plus Levonorgestrel Vaginal Rings in Women
- Pharmacological Activation of Cannabinoid-2 Receptor Reduces Acute Lung Injury and Inflammation Induced by 2-chloroethyl Ethyl Sulfide
- Pharmacological Activation of Cannabinoid-2 Receptor Reduces SARS-CoV-2-Spike Protein-Induced Acute Lung Injury and Inflammation
- PHASE 2 TRIAL OF NEOADJUVANT AND ADJUVANT PD-1 CHECKPOINT BLOCKADE IN LOCAL-REGIONALLY ADVANCED, RESECTABLE HNSCC INDICATES PATHOLOGICAL RESPONSE IS ASSOCIATED WITH HIGH DISEASE-FREE SURVIVAL
- PHASE 3 TRIAL RESULTS: EFFICACY AND SAFETY OF ELAGOLIX IN A SUBSET OF WOMEN WITH UTERINE FIBROIDS AND ADENOMYOSIS.
- Phencyclidine exposures reported to the US Poison Centers
- Phosphorylation of SAMHD1 in Brain Macrophages Increases with Viral Loads in the Brains of SIV-Infected Rhesus Macaques
- PHYSICAL THERAPY FOR ORCHIALGIA: TREATMENT MODALITIES
- PHYSICAL THERAPY FOR PELVIC PAIN AND ORCHALGIA IN MEN
- Placental Estrogen Suppresses Cyclin D1 Expression in the Nonhuman Primate Fetal Adrenal Cortex
- Placental evaluation using novel ultrasound tools in association with adverse pregnancy outcome: prospective longitudinal study
- Placental pathology and correlation with detection of intrauterine growth restriction in twin pregnancies
- Placental phenotype in non-immune hydrops fetalis
- Plagiocephaly Helmet Crowdfunding Across the US